Patents by Inventor Pascal Drevet

Pascal Drevet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods For Treating Agitation In Subjects With Mild Cognitive Impairment Or Major Neurocognition Disorder
    Publication number: 20240122928
    Abstract: The present invention relates to a method of treating agitation in a human patient with dementia, comprising administering to the human patient with dementia in need thereof a pharmaceutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt or hydrate thereof to treat agitation, wherein R1-R4 are defined herein: wherein the human patient has at least an about 20% reduction in their symptom of agitation, relative to the patient prior to administration of the compound of formula (I).
    Type: Application
    Filed: December 5, 2023
    Publication date: April 18, 2024
    Inventors: Wayne Drevets, Pascal Bonaventure, Gahan Pandina
  • Stabilized Tat antigen and the use thereof for anti-HIV vaccination
    Patent number: 8501193
    Abstract: The invention relates to a vaccine composition comprising at least one type of anti-HIV vaccine composition containing at least one type of stabilized Tat antigen and to the use thereof for preventing and/or treating a human HIV infection.
    Type: Grant
    Filed: April 1, 2005
    Date of Patent: August 6, 2013
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Pascal Drevet, Evelyne Lajeunesse, Alain Lecoq, Michel Leonetti, André Menez, Gervaise Moine, Robert Thai